Lainé-Bidron C - Search Results

1

Reverse transcription-polymerase chain reaction (RT-PCR) assays of estrogen and progesterone receptors in breast cancer.

Chevillard S, Müller A, Levalois C, Lainé-Bidron C, Vielh P, Magdelénat H. Chevillard S, et al. Among authors: laine bidron c. Breast Cancer Res Treat. 1996;41(1):81-9. doi: 10.1007/BF01807039. Breast Cancer Res Treat. 1996. PMID: 8932879

2

Genetic evolution of breast cancer: II. Relationship with estrogen and progesterone receptor expression.

Magdelenat H, Gerbault-Seureau M, Laine-Bidron C, Prieur M, Dutrillaux B. Magdelenat H, et al. Among authors: laine bidron c. Breast Cancer Res Treat. 1992;22(2):119-27. doi: 10.1007/BF01833341. Breast Cancer Res Treat. 1992. PMID: 1391976

3

Immunoenzymatic (EIA) assays of estrogen and progesterone receptors in fine-needle and surgical samples in breast cancer patients.

Klijanienko J, Lainé-Bidron C, Vielh P, Magdelénat H. Klijanienko J, et al. Among authors: laine bidron c. Am J Clin Pathol. 1995 Sep;104(3):289-93. doi: 10.1093/ajcp/104.3.289. Am J Clin Pathol. 1995. PMID: 7677117

4

Estrogen receptor negative and progesterone receptor positive primary breast cancer: pathological characteristics and clinical outcome. Institut Curie Breast Cancer Study Group.

Bernoux A, de Cremoux P, Lainé-Bidron C, Martin EC, Asselain B, Magdelénat H. Bernoux A, et al. Among authors: laine bidron c. Breast Cancer Res Treat. 1998 Jun;49(3):219-25. doi: 10.1023/a:1006011328655. Breast Cancer Res Treat. 1998. PMID: 9776505

5

Progesterone receptor detection and quantification in breast tumors by bivariate immunofluorescence/DNA flow cytometry.

Remvikos Y, VuHai M, Lainé-Bidron C, Jollivet A, Magdelénat H. Remvikos Y, et al. Among authors: laine bidron c. Cytometry. 1991;12(2):157-66. doi: 10.1002/cyto.990120210. Cytometry. 1991. PMID: 2049973 Free article.

6

A simplified immuno-enzymetric assay of the epidermal growth factor receptor in breast tumors: evaluation in 282 cases.

Grimaux M, Mady E, Remvikos Y, Laine-Bidron C, Magdelenat H. Grimaux M, et al. Int J Cancer. 1990 Feb 15;45(2):255-62. doi: 10.1002/ijc.2910450209. Int J Cancer. 1990. PMID: 2406203

7

Immunoenzymetric assay of epidermal growth factor receptor. Application to breast tumor samples.

Grimaux M, Lainé-Bidron C, Magdelénat H. Grimaux M, et al. Tumour Biol. 1989;10(4):215-24. doi: 10.1159/000217618. Tumour Biol. 1989. PMID: 2675297

8

Steroid receptor distribution in 47,892 breast cancers. A collaborative study of 7 European laboratories. The EORTC Receptor Study Group.

Romain S, Lainé Bidron C, Martin PM, Magdelenat H. Romain S, et al. Among authors: laine bidron c. Eur J Cancer. 1995;31A(3):411-7. doi: 10.1016/0959-8049(94)00496-r. Eur J Cancer. 1995. PMID: 7786610

9

Plasminogen activator inhibitor-1 (PAI-1) is not related to response to neoadjuvant chemotherapy in breast cancer.

Pierga JY, Lainé-Bidron C, Beuzeboc P, De Crémoux P, Pouillart P, Magdelénat H. Pierga JY, et al. Among authors: laine bidron c. Br J Cancer. 1997;76(4):537-40. doi: 10.1038/bjc.1997.421. Br J Cancer. 1997. PMID: 9275033 Free PMC article.

10

Estrogen and progestin receptor assay in fine needle aspirates of breast cancer: methodological aspects.

Magdelenat H, Laine-Bidron C, Merle S, Zajdela A. Magdelenat H, et al. Eur J Cancer Clin Oncol. 1987 Apr;23(4):425-31. doi: 10.1016/0277-5379(87)90381-6. Eur J Cancer Clin Oncol. 1987. PMID: 3609107

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14 results

Search Page

Filters